Description
Taylor & Francis Pharmacotherapy for Child and Adolescent Psychiatric Disorders 2002 Edition by David Rosenberg, Samuel Gershon
The Second Edition of Pharmacotherapy for Child and Adolescent Psychiatric Disorders contains new and expanded chapters oncombination therapy pharmacoepidemiology pharmacoeconomics current social, ethical, and legal issues surrounding the administration of psychostimulants and antidepressants to children and teenagers serotonin reuptake inhibitors and discusses techniques to select the most appropriate drug and dosing schedule methods to adjust safely and tailor medical treatments for children during various stages of growth and development the effect of psychoactive drugs on cardiac function Offering nearly 3000 contemporary references to facilitate further research, Pharmacotherapy for Child and Adolescent Psychiatric Disorders, Second Edition is a timely and authoritative guide suitable for psychiatrists, psychologists, pediatricians, pharmaceutical and behavioral scientists, clinical neurologists, primary care physicians, social workers, and graduate and medical school students in these disciplines. Table of contents :- INTRODUCTION TO PSYCHOPHARMACOLOGYHistorical Perspective on Child and Adolescent PsychopharmacologySamuel GershonEthical Issues in Pediatric Psychopharmacology ResearchBenedetto VitielloPharmacoepidemiology of Psychotropic Medications in YouthDaniel J. Safer and Julie Magno ZitoChild and Adolescent Psychopharmacology: A Call for Pharmacoeconomics ResearchJunius J. Gonzales and Beth BowersClinical Pharmacology of Psychoactive Drugs in Childhood and AdolescenceDavid J. EdwardsCardiac Side Effects of Psychotropic Medications in Children and AdolescentsVikram K. YeraganiCLASSES OF MEDICATIONPsychostimulantsDavid R. RosenbergTricyclic AntidepressantsDavid R. RosenbergSelective Serotonin-Reuptake InhibitorsDavid R. RosenbergNovel (Atypical) AntidepressantsPablo A. DavanzoMonoamine Oxidase InhibitorsPablo A. DavanzoAntipsychotic AgentsPablo A. Davanzo Lithium